<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04693221</url>
  </required_header>
  <id_info>
    <org_study_id>2020-05</org_study_id>
    <secondary_id>2020-A02657-32</secondary_id>
    <nct_id>NCT04693221</nct_id>
  </id_info>
  <brief_title>Optimization of the Parameters of Vagal Nerve Stimulation</brief_title>
  <acronym>OPSTIMVAG</acronym>
  <official_title>Optimization of the Parameters of Vagal Nerve Stimulation in Pharmaco- Resistant Epileptic Patients Based on a Surface EEG Index of Functional Connectivity (PLI: Phase Lag Index): a Randomized Double-blind Multicenter Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vagal nerve stimulation (VNS) is one of the neuromodulation techniques that can be indicated&#xD;
      in patients suffering from refractory epilepsies, especially when an open resection has&#xD;
      failed or is not indicated. However to date it is not possible to predict which patients will&#xD;
      respond and what are the best parameters of stimulation to be set (pulse width, frequency and&#xD;
      intensity). It has been shown that responders to VNS have reduced interictal cortical&#xD;
      synchronicity on scalp EEG based on phase lag index (PLI), a marker of functional&#xD;
      connectivity (Fc) The aim of this study is to test the following hypothesis: setting the&#xD;
      parameters of stimulation on the basis of the lowest values of Phase Lag Index (PLI) obtained&#xD;
      on scalp EEG with different settings of parameters (as compared with a randomly chosen set of&#xD;
      commonly used parameters) will increase the rate of responders to VNS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean number of seizures per month</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean number of seizures per month</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of responders in each group</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of responders in each group</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of generalized seizures</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of generalized seizures</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of seizures with falls</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of seizures with falls</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of seizures with alteration of consciousness</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of seizures with alteration of consciousness</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of depression</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
    <description>NDDI-E</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of depression</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
    <description>NDDI-E</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of anxiety</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
    <description>GAD-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of anxiety</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
    <description>GAD-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of quality of life</measure>
    <time_frame>Change from baseline to 6 months</time_frame>
    <description>QUOLIE 31</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of quality of life</measure>
    <time_frame>Change from baseline to 12 months</time_frame>
    <description>QUOLIE 31</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>VNS therapy with randomly-set combination of parameters (similar to current practice)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VNS therapy with set combination of parameters chosen based on the lowest phase lag index</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Choice of VNS set of parameters based on the lowest PLI</intervention_name>
    <description>Vagal nerve stimulation according to PLI results.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>Patient will have an EEG and 12 sets of parameters will be tested. EEG results will be analyzed which will allow to determine the set involving the lowest phase lag index.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female epileptic patients over 12 years of age&#xD;
&#xD;
          -  Suffering from pharmaco-resistant epilepsy&#xD;
&#xD;
          -  With newly implanted VNS Aspire SR device&#xD;
&#xD;
          -  Surgery performed in the previous 6 months&#xD;
&#xD;
          -  Electrode impedance should be within normal range ( &lt; 4000 Ohms)&#xD;
&#xD;
          -  Auto-stim mode working properly&#xD;
&#xD;
          -  Mean number of seizures of at least (average 4 (mean value) / months during the&#xD;
             baseline period)&#xD;
&#xD;
          -  Patient, parents or legally representatives who have given written informed consent to&#xD;
             allow the study data collection and procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Difficulty to read or understand the French language, or inability to understand the&#xD;
             information regarding the study&#xD;
&#xD;
          -  Total patient's IQ below 64&#xD;
&#xD;
          -  Subject in exclusion period due to enrolment in another study&#xD;
&#xD;
          -  Patient with postoperative left vocal cord paralysis&#xD;
&#xD;
          -  Patient on VNS since more than 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Olivier ARNAUD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romain Carron</last_name>
    <phone>0672274154</phone>
    <email>romain.carron@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabrice Bartolomei</last_name>
    <phone>0491385829</phone>
    <email>fabrice.bartolomei@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital St Joseph St Luc</name>
      <address>
        <city>Lyon</city>
        <state>FRA</state>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrien Didelot</last_name>
      <email>adidelot@ch-stjoseph-stluc-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of functional explorations of the nervous system, CHU</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William Szurhaj</last_name>
      <email>szurhaj.william@chu-amiens.fr</email>
    </contact>
    <contact_backup>
      <last_name>Michel Lefranc</last_name>
      <email>lefranc.michel@chu-amiens.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neuropediatrics department, CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Van Bogaert</last_name>
      <email>patrick.vanbogaert@chu-angers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Matthieu Delon</last_name>
      <email>matthieu.delion@chu-angers.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurology Department, CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie De Montaudouin</last_name>
      <email>marie.demontaudouin@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Guillaume Penchet</last_name>
      <email>guillaume.penchet@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinical neurophysiology, CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine Lemesle</last_name>
      <email>martine.lemesle@chu-dijon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Catherine Cao</last_name>
      <email>catherine.cao@chu-dijon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Epilepsy neurophysiopathology department, CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe Kahane</last_name>
      <email>pkahane@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical neurophysiology, CHU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Derambure</last_name>
      <email>philippe.derambure@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvain Rheims</last_name>
      <email>sylvain.rheims@univ-lyon1.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marc Guénot</last_name>
      <email>marc.guenot@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of clinical neurophysiology, Hôpital La Timone, APHM</name>
      <address>
        <city>Marseille</city>
        <zip>13885</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Carron</last_name>
    </contact>
    <contact_backup>
      <last_name>Fabrice Bartolomei</last_name>
      <email>fabrice.bartolomei@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurology Department</name>
      <address>
        <city>Marseille</city>
        <zip>84072</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Godet</last_name>
      <email>bertrand.godet@unilim.fr</email>
    </contact>
    <contact_backup>
      <last_name>François Caire</last_name>
      <email>francois.caire@chu-limoges.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurosurgery Department, CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie Colnat-Coulbois</last_name>
    </contact>
    <contact_backup>
      <email>s.coulbois@chru-nancy.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurosurgery Department, CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvie Raoul</last_name>
      <email>sylvie.raoul@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurosurgery Department, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Mathon</last_name>
      <email>bertrand.mathon@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurophysiology Department</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martine Gavaret</last_name>
      <email>m.gavaret@ghu-paris.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marc Zanello</last_name>
      <email>m.zanello@ch-sainte-anne.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Epileptology Department, CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arnaud Biraben</last_name>
      <email>arnaud.biraben@univ-rennes1.fr</email>
    </contact>
    <contact_backup>
      <last_name>Claire Haegelen</last_name>
      <email>claire.haegelen@chu-rennes.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurophysiology Department, CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Chastan</last_name>
      <email>nathalie.chastan@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stéphane Derrey</last_name>
      <email>stephane.derrey@chu-rouen.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurology Department, CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edouard Hirsch</last_name>
      <email>edouard.hirsch@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurophysiological explorations, Hôpital Pierre Paul Riquet, Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc Valton</last_name>
      <email>valton.l@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean Christophe Sol</last_name>
      <email>sol.jc@chu-toulouse.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurology and clinical neurophysiology, CHU Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julien Biberon</last_name>
      <email>j.biberon@chu-tours.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 31, 2020</study_first_submitted>
  <study_first_submitted_qc>December 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>July 18, 2021</last_update_submitted>
  <last_update_submitted_qc>July 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>vagal nerve stimulation</keyword>
  <keyword>phase lag index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

